Abstract
Generally, prostaglandins (PG) are unstable and insoluble in water, though they exhibit strong biological activities in minute amount. The most difficult problem in developing PG preparations is how to stabilize and solubilize PG without loss of their activities. We have successfully developed the pharmaceutical preparations contaning PG complexes with cyclodextrins (CD). These preparations are already on the market, namely PGE2 ·β-CD Tablet and PGE1 ·α-CD Injection. Moreover, PG and PGI2 derivatives are now under development as a form of CD complex.
Similar content being viewed by others
References
S. Bergström and J. Sjövall, Acta Chem. Scand. 14, 1693 (1960).
E. J. Corey, I. Vlattas and K. Harding, J. Am. Chem. Soc. 91, 535 (1969).
Ono Pharmaceutical Co. Jap. Pat. 790979 (1975).
Ono Pharmaceutical Co. Jap. Pat. 1007787 (1980).
Ono Pharmaceutical Co. Jap. Kokai 54-103844 (1979).
K. Uekama, F. Hirayama, K. Ikeda, and K. Inaba, J. Pharm. Sci. 66, 706–711 (1977).
K. Uekama and F. Hirayama, Chem. Pharm. Bull. 26, 1195–1200 (1978).
K. Uekama, F. Hirayama, T. Wakuda, and M. Otagiri, Chem. Pharm. Bull. 29, 213–219 (1981).
K. Uekama, F. Hirayama, A. Fujise, M. Otagiri, K. Inaba, and H. Saito, J. Pharm. Sci. 73, 382–384 (1984).
K. Uekama, A. Fujise, F. Hirayama, M. Otagiri, and K. Inaba, Chem. Pharm. Bull. 32, 275–279 (1984).
T. Higuchi and K.A. Connors, Adv. Anal. Chem. Instr. 4, 117–212 (1965).
F. Hirayama, M. Otagiri, K. Uekama, and K. Inaba, Kobunshi Ronbunshu 39, 643–648 (1982).
K. Takeo and T. Kuge, Agr. Biol. Chem. 34, 1787–1795 (1970).
K. Uekama, F. Hirayama, Y. Yamada, K. Inaba, and K. Ikeda, J. Pharm. Sci. 68, 1059–1060 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inaba, K., Wakuda, T. & Uekama, K. Prostaglandins and their cyclodextrin complexes. Journal of Inclusion Phenomena 2, 467–474 (1984). https://doi.org/10.1007/BF00662213
Issue Date:
DOI: https://doi.org/10.1007/BF00662213